Download presentation
Presentation is loading. Please wait.
Published byClaire Hilary Douglas Modified over 5 years ago
1
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T. Wong, MD, David Schwartz, MD, Joseph P. Weiner, MD, Virginia W. Osborn, MD, David Schreiber, MD The Annals of Thoracic Surgery Volume 102, Issue 2, Pages (August 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Kaplan-Meier survival estimates were derived for patients with pathologic complete response (pCR) and residual disease after esophagectomy. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.